Earnings
BNTC
4.220
+1.20%
0.050
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-06-30
9.80M
87.00K
--
59.00K
--
--
0.00
--
--
--
861.00K
1000.00
10.81M
769.00K
--
9000.00
--
--
--
--
--
778.00K
11.59M
--
282.00K
0.00
--
--
--
--
--
604.00K
--
--
--
250.00K
1.14M
0.00
--
--
--
213.00K
213.00K
1.35M
1000.00
128.83M
-116.64M
--
--
--
10.24M
10.24M
11.59M
FY 2019-06-30
15.61M
126.10K
--
2.52M
--
--
0.00
--
--
--
372.73K
372.73K
18.63M
466.79K
--
9057.10
--
--
--
--
--
475.85K
19.11M
--
1.46M
0.00
--
--
--
1.01M
--
139.34K
--
--
--
6967.00
2.62M
0.00
--
--
--
0.00
0.00
2.62M
114.32M
--
-96.81M
--
--
--
16.48M
16.48M
19.11M
FY 2019-06-30
17.08M
137.94K
--
2.76M
--
--
0.00
--
--
--
407.73K
--
20.38M
510.61K
--
9907.00
--
--
--
--
--
520.51K
20.90M
--
1.60M
0.00
--
--
--
1.11M
--
152.42K
--
--
--
7621.00
2.87M
0.00
--
--
--
0.00
0.00
2.87M
125.05M
--
-105.90M
--
--
--
18.03M
18.03M
20.90M
FY 2018-06-30
11.91M
96.25K
--
3.15M
--
--
0.00
--
--
--
--
314.67K
15.47M
236.19K
--
92.55K
--
--
--
--
--
328.74K
15.80M
--
1.76M
0.00
--
--
--
--
--
--
--
--
--
126.61K
1.89M
0.00
--
--
--
35.54K
35.54K
1.92M
121.49M
--
-107.61M
--
--
--
13.88M
13.88M
15.80M
FY 2018-06-30
12.26M
99.07K
--
3.24M
--
--
0.00
--
--
--
--
323.89K
15.92M
243.11K
--
95.26K
--
--
--
--
--
338.37K
16.26M
--
1.81M
0.00
--
--
--
--
--
--
--
--
--
130.32K
1.94M
0.00
--
--
--
36.58K
36.58K
1.98M
125.05M
--
-110.77M
--
--
--
14.28M
14.28M
16.26M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out BNTC latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Benitec Biopharma recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.